L-arginine in pregnant scleroderma patients

Clinical Rheumatology

Volumn 29, Issue 8, 2010, Pages 937-939

  Giuggioli, Dilia ^a,b   Colaci, Michele ^a   Sebastiani, Marco ^a   Ferri, Clodoveo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

L arginine; Pregnancy; Scleroderma

Indexed keywords

ARGININE; NITRIC OXIDE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HIGH RISK PREGNANCY; HUMAN; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; LUNG DISEASE; NEWBORN; PREECLAMPSIA; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; SCLERODERMA; SYSTEMIC SCLEROSIS; COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PILOT STUDY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

ADMINISTRATION, ORAL; ADULT; ARGININE; FEMALE; HUMANS; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; PILOT PROJECTS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; SCLERODERMA, SYSTEMIC;

EID: 77956265507     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1396-4     Document Type: Article

References (17)

1. Medsger TA Jr. (2001) Systemic sclerosis (scleroderma): clinical aspects. In: Koopman WJ (ed) Arthritis and allied conditions, 14th ed. Lippincott Williams & Wilkins, Philadelphia, pp 1590-1624
2. Ferri C, Valentini G, Cozzi F et al (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1, 012 Italian patients. Medicine 81:139-153
3. Steen VD (1999) Pregnancy in women with systemic sclerosis. Obstet Gynecol 94:15-20
4. Miniati I, Guiducci S, Mecacci F, Mello G, Matucci-Cerinic M (2008) Pregnancy in systemic sclerosis. Rheumatology 47 (Suppl 3): iii16-iii18
5. Palmer RM, Ashton DS, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664-666
6. Facchinetti F, Longo M, Piccinini F et al (1999) L-Arginine infusion reduces blood pressure in preeclamptic women through nitric oxide release. J Soc Gynecol Invest 6:202-207
7. Staff AC, Berge L, Haugen G et al (2004) Dietary supplementation with L-arginine or placebo in women with pre-eclampsia. Acta Obstet Gynecol Scand 83:103-107
8. Rytlewsky K, Olszanecki R, Lauterbach R, Grzyb A, Basta A (2006) Effects of oral L-arginine on the foetal condition and neonatal outcome in preeclampsia: a preliminary report. Basic Clin Pharmacol Toxicol 99:146-152
9. No authors listed (1980) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590
10. Carbonne B, Macé G, Cynober E et al (2007) Successful pregnancy with the use of nitric oxide donors and heparin after recurrent severe preeclampsia in a woman with scleroderma. Am J Obstet Gynecol 197:6-7
11. Xiao XM, Li LP (2005) L-Arginine treatment for asymmetric fetal growth restriction. Int J Gynecol Obstet 88:15-18
12. Baylis C (2006) Arginine, arginine analogs and nitric oxide production in chronic kidney disease. Nat Clin Pract Nephrol 2:209-220
13. Junbao D, Hui Y, Bing W et al (2005) Effect of l-arginine on collagen of high flow-induced pulmonary arterial remodelling. Circ J 69:603-608
14. Takagi K, Kawaguchi Y, Hara M (2003) Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features. Clin Exp Immunol 134:538-544
15. Pernow J, Bohm F, Beltran E et al (2003) L-Arginine protects from ischemia-reperfusion-induced endothelial dysfunction in humans in vivo. J Appl Physiol 95:2218-2222
16. Rembold CM, Ayers CR (2003) Oral l-arginine can reverse digital necrosis in Raynaud's phenomenon. Mol Cell Biochem 244:139-141
17. Collier SR, Casey DP, Kanaley JA (2005) Growth hormone responses to varying doses of oral arginine. Growth Horm IGF Res 15:136-139